financetom
Business
financetom
/
Business
/
Cholamandalam Financial Q4 standalone net at Rs 34.26 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cholamandalam Financial Q4 standalone net at Rs 34.26 crore
May 4, 2019 9:25 AM

Cholamandalam Financial Holdings Ltd has clocked standalone net profit for the quarter ending March 31, 2019, at Rs 34.26 crore, up from Rs 33.60 crore registered a year ago.

The city-based firm, formerly known as TI Financial Holdings Ltd, clocked net profit at Rs 66.53 crore for the year ending March 31, 2019, compared to Rs 59.39 crore in the same period last year.

The standalone total income for the January-March 2019 quarter grew to Rs 36.47 crore from Rs 35.61 crore, a company release said.

For the full year ending March 31, 2019, standalone total income went up to Rs 73.52 crore from Rs 64.67 crore. Cholamandalam Investment and Finance Company disbursed loans totalling Rs 30,451 crore for the year March 31, 2019 as compared to Rs 25,114 crore the previous year.

Cholamandalam MS General Insurance Company Ltd registered a gross written premium of Rs 4,552 crore for the year ending March 31, 2019 as against Rs 4,113 crore in the year-ago period.

Cholamandalam MS Risk Services Ltd, a joint venture company, registered a revenue of Rs 40.72 crore as against Rs 56.28 crore. The Board of Directors of the company have recommended a final dividend of 65 percent being Rs 0.65 per share on the equity shares of the company for year ending March 31,2019.

The aggregate dividend recommended is Rs 1.25 per share, it added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MaxCyte Licenses Cell-Engineering Technology to TG Therapeutics
MaxCyte Licenses Cell-Engineering Technology to TG Therapeutics
Feb 12, 2025
04:16 AM EST, 02/12/2025 (MT Newswires) -- MaxCyte ( MXCT ) said Wednesday it is licensing its cell-engineering technology to TG Therapeutics ( TGTX ) . Financial terms were not disclosed. Under the terms of the agreement, TG Therapeutics ( TGTX ) will gain non-exclusive research, clinical and commercial rights to use MaxCyte's ( MXCT ) Flow Electroporation technology and...
Zurn Elkay Water Solutions Prices Common Shares Offering by Selling Stockholder
Zurn Elkay Water Solutions Prices Common Shares Offering by Selling Stockholder
Feb 12, 2025
04:19 AM EST, 02/12/2025 (MT Newswires) -- Zurn Elkay Water Solutions ( ZWS ) said late Tuesday it priced an underwritten public offering of about 7.8 million of its common shares launched by former stockholder Ice Mountain at $35 apiece. The company has granted the underwriters a 30-day option to buy up to an additional 1.2 million of its common...
Update: Phillips 66 Faces Pressure From Elliott as Activist Builds Over $2.5 Billion Stake
Update: Phillips 66 Faces Pressure From Elliott as Activist Builds Over $2.5 Billion Stake
Feb 12, 2025
04:26 AM EST, 02/12/2025 (MT Newswires) -- (Updates with a response from Phillips 66 in the last two paragraphs and attribution to a statement from Elliot Investment Management) Phillips 66 (PSX) is facing pressure from Elliott Investment Management to sell or spin off its midstream business as the activist investor has built up a stake worth more than $2.5 billion...
Moonshot firm ispace upbeat as Trump keeps Artemis lunar missions with Japan
Moonshot firm ispace upbeat as Trump keeps Artemis lunar missions with Japan
Feb 12, 2025
TOKYO (Reuters) - Tokyo-based moon exploration company ispace is heartened by signs the United States and Japan will remain on course for joint lunar missions, its CEO said on Wednesday, amid growing uncertainties in U.S. space policies under Trump 2.0. The view by ispace chief executive Takeshi Hakamada came after a meeting last weekend between U.S. President Donald Trump and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved